Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Khalifa Kush Enterprises Canada partnered with Supreme Cannabis to launch branded cannabis products including flower, oil, pre-rolls, extracts, and capsules for the Canadian adult-use market, but the partnership was mutually terminated in August 2020. No clinical trial results; products are adult-use recreational with no pharmaceutical claims. The company was solely focused on premium cannabis brand extension, not drug/pharma development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Khalifa Kush Enterprises Canada.